Author

Martin Sebastian Winkler

Universitätsmedizin GöttingenORCID 0000-0002-3328-5175Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Organism:human· 4 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Hans‐Martin JäckiD· 5 shared Luise Graichen· 5 shared Markus HoffmanniD· 5 shared Nadine KrügeriD· 5 shared Sebastian R. SchulziD· 5 shared Stefan PöhlmanniD· 5 shared Amy Madeleine Kempf· 4 shared Georg M. N. BehrensiD· 3 shared

Activity by Year

2020-2024 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersMolecular Biology

Hans‐Martin JäckORCID

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Molecular BiologybioRxivPreprintApr 18, 2024

ACE2-independent sarbecovirus cell entry is supported by TMPRSS2-related enzymes and reduces sensitivity to antibody-mediated neutralization

Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger…·Markus Hoffmann

This study identifies an ACE2-independent pathway for sarbecovirus entry in human cells, mediated by TMPRSS2-related proteases and linked to reduced antibody neutralization.

3 citations

humanexperimental assay

𝕏 PostBluesky

Molecular BiologyCell ReportsPeer-reviewedJun 29, 2021

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination

Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger…·Stefan Pöhlmann

258 citationstop 1%

experimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJun 23, 2021

Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccination

Prerna Arora, Amy Madeleine Kempf, Inga Nehlmeier…·Markus Hoffmann

This study shows that the B.1.617.2 variant of SARS-CoV-2 evades antibodies from infection and vaccination, increases lung cell entry, and enhances cell fusion.

20 citations

experimental assay

𝕏 PostBluesky

Molecular BiologyCell ReportsPeer-reviewedApr 1, 2021

SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization

Markus Hoffmann, Lu Zhang, Nadine Krüger…·Stefan Pöhlmann

The paper shows that SARS-CoV-2 mutations from mink reduce antibody neutralization, suggesting potential risks for human infections.

90 citationstop 3%

mousehuman

𝕏 PostBluesky

Molecular BiologyCellPeer-reviewedMar 20, 2021

SARS-CoV-2 variants B.1.351 and B.1.1.248: Escape from therapeutic antibodies and antibodies induced by infection and vaccination

Markus Hoffmann, Prerna Arora, Rüdiger M. Groß…·Stefan Pöhlmann

940 citationstop 1%

humanexperimental assay

𝕏 PostBluesky

NeuroscienceNature NeurosciencePeer-reviewedNov 30, 2020

Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients

Jenny Meinhardt, Josefine Radke, Carsten Dittmayer…·Frank L. Heppner

The paper investigates SARS-CoV-2 entry into the CNS via the olfactory mucosa in COVID-19 patients and demonstrates neurotropism and cerebral thromboembolism.

1,458 citationstop 1%

humanexperimental assay

𝕏 PostBluesky